» Articles » PMID: 27178736

Golden Gate Assembly of CRISPR GRNA Expression Array for Simultaneously Targeting Multiple Genes

Overview
Publisher Springer
Specialty Biology
Date 2016 May 15
PMID 27178736
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The engineered CRISPR/Cas9 technology has developed as the most efficient and broadly used genome editing tool. However, simultaneously targeting multiple genes (or genomic loci) in the same individual cells using CRISPR/Cas9 remain one technical challenge. In this article, we have developed a Golden Gate Assembly method for the generation of CRISPR gRNA expression arrays, thus enabling simultaneous gene targeting. Using this method, the generation of CRISPR gRNA expression array can be accomplished in 2 weeks, and contains up to 30 gRNA expression cassettes. We demonstrated in the study that simultaneously targeting 10 genomic loci or simultaneously inhibition of multiple endogenous genes could be achieved using the multiplexed gRNA expression array vector in human cells. The complete set of plasmids is available through the non-profit plasmid repository Addgene.

Citing Articles

RMD and Its Suppressor MAPK6 Control Root Circumnutation and Obstacle Avoidance via BR Signaling.

Dong L, Shi J, Persson S, Huang G, Zhang D Int J Mol Sci. 2024; 25(19).

PMID: 39408870 PMC: 11477179. DOI: 10.3390/ijms251910543.


A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genes.

Ellis N, Myers K, Tung J, Davidson Ward A, Johnston K, Bonnington K Elife. 2023; 12.

PMID: 38095310 PMC: 10721215. DOI: 10.7554/eLife.86903.


An efficient cloning method to expand vector and restriction site compatibility of Golden Gate Assembly.

Sorida M, Bonasio R Cell Rep Methods. 2023; 3(8):100564.

PMID: 37671021 PMC: 10475842. DOI: 10.1016/j.crmeth.2023.100564.


AspFlex: Molecular Tools to Study Gene Expression and Regulation in .

Brychcy M, Kokodynski A, Lloyd D, Godoy V ACS Synth Biol. 2023; 12(9):2773-2777.

PMID: 37587063 PMC: 10621034. DOI: 10.1021/acssynbio.3c00167.


A randomized multiplex CRISPRi-Seq approach for the identification of critical combinations of genes.

Ellis N, Myers K, Tung J, Davidson Ward A, Johnston K, Bonnington K bioRxiv. 2023; .

PMID: 36945652 PMC: 10028747. DOI: 10.1101/2023.02.03.527066.


References
1.
Tu Z, Yang W, Yan S, Guo X, Li X . CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases. Mol Neurodegener. 2015; 10:35. PMC: 4524001. DOI: 10.1186/s13024-015-0031-x. View

2.
Fujita T, Fujii H . Efficient isolation of specific genomic regions and identification of associated proteins by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) using CRISPR. Biochem Biophys Res Commun. 2013; 439(1):132-6. DOI: 10.1016/j.bbrc.2013.08.013. View

3.
Konermann S, Brigham M, Trevino A, Joung J, Abudayyeh O, Barcena C . Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2014; 517(7536):583-8. PMC: 4420636. DOI: 10.1038/nature14136. View

4.
Chen B, Gilbert L, Cimini B, Schnitzbauer J, Zhang W, Li G . Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell. 2013; 155(7):1479-91. PMC: 3918502. DOI: 10.1016/j.cell.2013.12.001. View

5.
Zhou Y, Liu Y, Hussmann D, Brogger P, Al-Saaidi R, Tan S . Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system. Cell Mol Life Sci. 2016; 73(13):2543-63. PMC: 11108510. DOI: 10.1007/s00018-015-2128-3. View